1801.HK | Innovent Biologics IncCategory: Consumer goods
Quick infos
Company ProfileEstablished in 2011, Innovent is committed to developing, manufacturing and commercializing high quality innovative medicines for the treatment of oncology, autoimmune, metabolic and other major diseases. On October 31, 2018, Innovent was listed on the Main Board of the Stock Exchange of Hong Kong Limited with the stock code: 01801.HK. Historical Data
HKSE - Hong Kong Stock Exchange More profiles and info about the company
NewsNews for (1801.HK)
This company doesn't provide a dividend. Talk about Innovent Biologics Inc below in comments section below.Do you think you'll buy? Do you already have active trades now? EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above. | NotesResearchInvestor pageinvestor.innoventbio.comIf you are looking for News & events, Press Release, they are available on their Investors Relationssite. Support this projectIf you want to help pay for server cost or for improving this tool. You can send it via Paypal. Social MediaRecommended BooksBuy on Amazon Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk. Take advantage of price swings in strongly trending securities and pump up your portfolio! |